Horizontal transfer of miR‐23a from hypoxic tumor cell colonies can induce angiogenesis TV Sruthi, L Edatt, GR Raji, H Kunhiraman, SS Shankar, V Shankar, ... Journal of Cellular Physiology 233 (4), 3498-3514, 2018 | 83 | 2018 |
Horizontal transfer of miR-106a/b from cisplatin resistant hepatocarcinoma cells can alter the sensitivity of cervical cancer cells to cisplatin GR Raji, TV Sruthi, L Edatt, K Haritha, SS Shankar, VBS Kumar Cellular signalling 38, 146-158, 2017 | 47 | 2017 |
2‐Deoxy Glucose modulates expression and biological activity of VEGF in a SIRT‐1 dependent mechanism H Kunhiraman, L Edatt, S Thekkeveedu, A Poyyakkara, V Raveendran, ... Journal of Cellular Biochemistry 118 (2), 252-262, 2017 | 29 | 2017 |
The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas K Katsushima, B Lee, H Kunhiraman, C Zhong, R Murad, J Yin, B Liu, ... Neuro-oncology 23 (4), 572-585, 2021 | 26 | 2021 |
Regulation of vascular endothelial growth factor by metabolic context of the cell VBS Kumar, S Binu, SJ Soumya, H K, PR Sudhakaran Glycoconjugate journal 31, 427-434, 2014 | 18 | 2014 |
MicroRNA106a regulates matrix metalloprotease 9 in a sirtuin‐1 dependent mechanism L Edatt, AK Maurya, G Raji, H Kunhiraman, SVB Kumar Journal of Cellular Physiology 233 (1), 238-248, 2018 | 15 | 2018 |
ER stress mediated regulation of miR23a confer Hela cells better adaptability to utilize glycolytic pathway A Poyyakkara, GR Raji, H Kunhiraman, L Edatt, SVB Kumar Journal of Cellular Biochemistry 119 (6), 4907-4917, 2018 | 13 | 2018 |
2-Deoxy glucose regulate MMP-9 in a SIRT-1 dependent and NFkB independent mechanism L Edatt, K Haritha, TV Sruthi, P Aswini, VB Sameer Kumar Molecular and cellular biochemistry 423, 197-206, 2016 | 11 | 2016 |
The paradoxical behavior of microRNA-211 in melanomas and other human cancers A Ray, H Kunhiraman, RJ Perera Frontiers in Oncology 10, 628367, 2021 | 6 | 2021 |
The LIN28B–let‐7–PBK pathway is essential for group 3 medulloblastoma tumor growth and survival SW Shahab, CM Roggeveen, J Sun, H Kunhiraman, LF McSwain, ... Molecular Oncology 17 (9), 1784-1802, 2023 | 5 | 2023 |
YB1 modulates the DNA damage response in medulloblastoma CCPAMK Leon F. McSwain, Claire E. Pillsbury, Ramona Haji-Seyed-Javadi ... Scientific Reports 13, 8087, 2023 | 2* | 2023 |
Regulation of poly ADP-ribosylation of VEGF by an interplay between PARP-16 and TNKS-2 H Kunhiraman, V Ramachandran, L Edatt, VB Sameer Kumar Molecular and Cellular Biochemistry 471, 15-27, 2020 | 2 | 2020 |
IGFBP2 promotes proliferation and cell migration through STAT3 signaling in Sonic hedgehog medulloblastoma H Kunhiraman, L McSwain, S Shahab, G Timothy, MD Tobey, K Anna Acta Neuropathol Commun., 2023 | 1 | 2023 |
MICRORNA 211, A POTENTIAL THERAPEUTIC AGENT FOR GROUP 3 MEDULLOBLASTOMA IN CHILDREN K Katsushima, B Lee, M Yuan, H Kunhiraman, S Stapleton, G Jallo, ... Neuro-Oncology 23, 40-40, 2021 | 1 | 2021 |
Horizontal transfer of miR-383 sensitise cells to cisplatin by targeting VEGFA-Akt signalling loop GR Raji, A Poyyakkara, TV Sruthi, L Edatt, K Haritha, SS Shankar, ... Molecular Biology Reports 51 (1), 1-22, 2024 | | 2024 |
miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4 M Yuan, I Mahmud, K Katsushima, K Joshi, O Saulnier, R Pokhrel, B Lee, ... Acta Neuropathologica Communications 11 (1), 203, 2023 | | 2023 |
Author Correction: YB1 modulates the DNA damage response in medulloblastoma LF McSwain, CE Pillsbury, R Haji‑Seyed‑Javadi, SK Rath, V Chen, ... Scientific Reports 13 (1), 9717, 2023 | | 2023 |
TMIC-81. INCREASED LEVEL OF IGFBP2 PROMOTES TUMOR METASTASIS IN SHH MEDULLOBLASTOMA H Kunhiraman, L McSwain, S Shahab, A Kenney Neuro-Oncology 24 (Suppl 7), vii289, 2022 | | 2022 |
INCREASED LEVEL OF IGFBP2 PROMOTES TUMOR METASTASIS IN SHH MEDULLOBLASTOMA AK Haritha Kunhiraman, Leon McSwain, Shubin Shahab Neuro-Oncology 24 (7), 2022 | | 2022 |
CSIG-34. LIN28B-LET-7-PBK PATHWAY IS AN IMPORTANT REGULATOR OF GROUP 3 MEDULLOBLASTOMA PROLIFERATION S Shahab, J Sun, H Kunhiraman, M Schneiderjan, K Juraschka, S Kumar, ... Neuro-Oncology 24 (Supplement_7), vii46-vii46, 2022 | | 2022 |